Assyro AI

FDA Orange Book · active-ingredient family

Flutamide

Flutamide is approved as 1 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:EULEXIN · NDA 018554

1

Brand (NDA)

5

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
EULEXINRLDSCHERINGNDA 018554Jan 27, 1989

Generic (ANDA) products (5)

ProductApplicantApplicationTEApproved
FLUTAMIDEPHARMOBEDIENTANDA 076224May 09, 2003
FLUTAMIDECIPLAANDA 075780Sep 19, 2001
FLUTAMIDEACTAVIS LABS FL INCANDA 075820Sep 18, 2001
FLUTAMIDECHARTWELL RXANDA 075818Sep 18, 2001
FLUTAMIDEWAYLIS THERAPANDA 075298Sep 18, 2001

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Flutamide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.